DMSI.US Dermisonics Inc

Healthcare Medical Devices USA Stocks
0.0000 USD
Close of Nov 18, 2025
Market cap
USD 1.92K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2007.

Is DMSI.US undervalued?

Graham number

The Graham number of Dermisonics Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Dermisonics Inc fundamental analysis

No fundamental analysis for Dermisonics Inc yet.

Dermisonics Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Dermisonics Inc

Dermisonics, Inc. manufactures ultrasonic transdermal drug-delivery technologies and equipment. It primarily focuses on the development, testing, and commercialization of its active transdermal patch, called the U-Strip, that has been designed to facilitate the needle-free delivery of drugs with large molecular structures, such as Insulin into the bloodstream. The company was formerly known as Second Stage Ventures, Inc. and changed its name to Dermisonics, Inc. in October 2…

Full company profile